We partner with these entrepreneurs to build profitable and impactful businesses.
We connect these businesses to our extensive network to help them scale.
We compound capital to honor our stakeholders.
We repeat from the beginning.
Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 22, 2026 | Think Bioscience Secures $55M Series A for 'Undruggable' Target Therapies | Think Bioscience, a Boulder, CO-based drug discovery innovator, closed an oversubscribed $55 million Series A funding round. This substantial investment accelerates R&D and operational expansion. The firm pioneers small molecule therape... |
| Jan 20, 2026 | Think Bioscience Raises $55M in Series A Funding | Think Bioscience, a Boulder, CO-based privately held small molecule drug discovery company, raised $55M in Series A funding. The round was led byRegeneron Ventures, Innovation Endeavors, and Janus Henderson Investors with participation from... |
| Nov 15, 2022 | University of Colorado Boulder spin-out Vitro3D raises $1.3M for volumetric 3D printing | Vote now for the 2022 3D Printing Industry Awards. Vitro3D, a volumetric 3D printing company has raised $1.3M in an oversubscribed seed round led by Buff Gold Ventures. According to the company, this funding can allow the production of prot... |
Reviews 0
FAQ about Buff Gold Ventures
When was Buff Gold Ventures founded?
Buff Gold Ventures was founded in 2022.
What has the press written about Buff Gold Ventures?
Parsers VC has collected 4 articles mentioning Buff Gold Ventures, among them “Think Bioscience Secures $55M Series A for 'Undruggable' Target Therapies” (Jan 22, 2026) and “Think Bioscience Raises $55M in Series A Funding” (Jan 20, 2026).
Is Buff Gold Ventures still active?
Yes, Buff Gold Ventures is active; its latest activity on Parsers VC dates from Sep 28, 2026.